Using data from the Parkinson's Progression Markers Initiative, GNS Healthcare identifies genetic and molecular markers of rapid motor progression.
PacBio is refining the CRISPR/Cas9 capture technique with several early- access sites and plans to launch it more broadly in 2018.
A meta-analysis based on genotyping data for more than 400,000 people with or without the disease led to 17 new risk loci mined for candidate genes
Clinical embryonic stem cell trials are set to begin in China, according to Nature News.
In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.
Protein researcher and former Whitehead Institute director Susan Lindquist has died.
In PNAS this week: work toward a CRISPR/Cas9-based approach to treat beta-thalassemia or sickle cell disease, bacteriophages uncovered in human stool, and more.
The study will screen patients using a combination of genotyping and wireless sensors to develop a better diagnostic method.
The firms said their test will be developed to detect levels of the tau protein that can leak into a person's bloodstream after head trauma or injury.
The NIH is seeking grant applications for projects focused on discovering biomarkers in Parkinson's disease and other Parkinsonian syndromes.
The New York Times reports that as China invests in science, it also is dealing with research fraud.
In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.
The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.
Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.